So here are my first dozen thoughts
And the AZ suit to derail the IRA zigs when others zag
And an updated version of my IRA lawsuit tracker
And the patient voice seems to have been lost in discussions about the IRA
And a NEJM piece argues that CMS is an HTA and should start acting accordingly
And the danger of using list prices when talking obesity meds
And the White House seems to be de-emphasizing certain parts of the IRA
And a fiesty war of words in JAMA about whether ex-US value judgments can be applied stateside
And Matt Herper resurrects a good idea that is two decades old
And insurance companies are refusing to cover Leqembi
Plus ranting about AARP, and how Daniel Heider is suddenly the most interesting person in pharma
And Patients for Affordable Drugs' questionable investment in meaningless minutiae